J-Pharma

Unleashing SLC Transporters Against Incurable Disease

We define our Corporate Philosophy as: "By pursuing new possibilities for SLC transporters and developing innovative new drugs that address unmet medical needs, we will contribute to supporting people around the world to maintain good health and hope."

Science

We select promising transporters from among SLC transporters as drug targets and analyze their functions and structures, which leads to drug discovery.

Pipeline

We are focusing on LAT1, an essential amino acid transporter discovered by J-Pharma’s founder, and developing several compounds for different indications.

About Us

Our core management policy is to continuously enhance corporate value by maintaining transparency with shareholders and other stakeholders and by ensuring efficient and effective management practices. J-Pharma has chosen a "company with Audit and Supervisory Committee" structure to match the scale and nature of our business and to promote efficient management.

News